Clearwater Paper (CLW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, with both in-person and virtual attendance options.
Shareholders are encouraged to review proxy materials and vote by May 6, 2026.
Voting matters and shareholder proposals
Election of five directors: Jeanne M. Hillman, Joe W. Laymon, Ann C. Nelson, John P. O'Donnell, and Christine M. Tucker, all recommended for approval.
Ratification of KPMG, LLP as independent registered public accounting firm for 2026.
Advisory vote to approve named executive officer compensation (say-on-pay).
Approval of amendment to Restated Certificate of Incorporation to limit liability of certain officers.
Approval of amendment to Bylaws to add a forum selection provision.
Approval of the 2026 Stock Incentive Plan.
Board of directors and corporate governance
Board recommends all director nominees and all proposals for shareholder approval.
Proposed amendments to governing documents address officer liability and legal forum selection.
Latest events from Clearwater Paper
- 2025 saw strong sales growth, cost savings, and major governance and ESG initiatives up for shareholder vote.CLW
Proxy filing27 Mar 2026 - Major transformation, cost savings, and ESG progress drive 2026 proxy proposals and governance.CLW
Proxy Filing5 Mar 2026 - Net sales up 12%, Adjusted EBITDA at $107M, but goodwill impairment drove a net loss.CLW
Q4 202518 Feb 2026 - Q2 net sales up 12% but net loss; tissue sale to reduce debt and boost paperboard focus.CLW
Q2 20242 Feb 2026 - Augusta mill acquisition boosts scale and reach as high utilization supports strong margins.CLW
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Augusta acquisition and tissue sale drove higher sales, debt reduction, and a paperboard focus.CLW
Q4 202422 Jan 2026 - Q3 sales and volumes rose, but margins fell; $100M buyback and debt reduction followed tissue sale.CLW
Q3 202416 Jan 2026 - Q1 net sales up 46% to $378M, with cost savings and Augusta synergies driving EBITDA growth.CLW
Q1 202523 Dec 2025 - Major strategic shifts, robust governance, and strong ESG focus define this proxy cycle.CLW
Proxy Filing1 Dec 2025